Cargando…

Imatinib-induced Ototoxicity in a Patient with Gastrointestinal Stromal Tumor (GIST)

Imatinib (Gleevec) is a biological agent that is approved for the treatment of chronic myeloid leukemia (CML) as well as gastrointestinal stromal tumor (GIST). The most frequently seen adverse effects in patients treated with imatinib include superficial edema, muscle cramps, musculoskeletal pain, r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wasif, Komal, Wasif, Nawal, Saif, Muhammad W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2016
Materias:	Otolaryngology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120973/ https://www.ncbi.nlm.nih.gov/pubmed/27909636 http://dx.doi.org/10.7759/cureus.848

Ejemplares similares

Ethnic Differences in Hematologic Toxicity from Imatinib in Patients with Gastrointestinal Stromal Cell Tumor (GIST): Coincidence or a Real Phenomenon
por: Saif, Muhammad Wasif, et al.
Publicado: (2019)

Imatinib-induced hyperbilirubinemia with UGT1A1 (*28) promoter polymorphism: first case series in patients with gastrointestinal stromal tumor
por: Saif, Muhammad Wasif, et al.
Publicado: (2016)

Imatinib treatment for gastrointestinal stromal tumour (GIST)
por: Lopes, Lisandro F, et al.
Publicado: (2010)

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
por: Quek, Richard, et al.
Publicado: (2010)

Bupropion-Induced Acute Dystonia with Dose Escalation and Use of Naranjo Nomogram
por: Wasif, Nawal, et al.
Publicado: (2017)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
por: Tang, Sumin, et al.
Publicado: (2017)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
por: Mohammadi, Mahmoud, et al.
Publicado: (2023)

Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity
por: Ghias, Adnan Asif Parvez, et al.
Publicado: (2018)

Ototoxicity of Triclosan: A Rat Model Study
por: Günebakan, Çağlar, et al.
Publicado: (2022)

Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells
por: Sako, Hiroyuki, et al.
Publicado: (2014)

Investigation of the Ototoxic Effect of Pembrolizumab Using a Rat Model
por: Kuzucu, İhsan, et al.
Publicado: (2019)

A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST)
por: Cappello, Giovanni, et al.
Publicado: (2023)

Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment
por: Deshaies, Isabelle, et al.
Publicado: (2010)

Targeting of FGF-Signaling Re-Sensitizes Gastrointestinal Stromal Tumors (GIST) to Imatinib In Vitro and In Vivo
por: Boichuk, Sergei, et al.
Publicado: (2018)

SPK1/S1P axis confers gastrointestinal stromal tumors (GISTs) resistance of imatinib
por: Chen, Yan, et al.
Publicado: (2022)

Evaluation of Alterations in Tumor Tissue of Gastrointestinal Stromal Tumor (GIST) in Computed Tomography Following Treatment with Imatinib
por: Werewka-Maczuga, Agnieszka, et al.
Publicado: (2017)

Spontaneous Non-Traumatic Mediastinal Hematoma in a Patient on Imatinib Therapy for a Gastrointestinal Stromal Tumor (GIST)
por: Aziz, Rida, et al.
Publicado: (2023)

The Utility of Frozen Sections in the Evaluation of Clear Margins in Oral Squamous Cell Carcinomas: A Cross-Sectional Study From a Tertiary Care Center
por: Wasif, Muhammad, et al.
Publicado: (2022)

Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)
por: Mahadevan, Daruka, et al.
Publicado: (2014)

Profile of patients with gastrointestinal stromal tumors (GIST)
por: PRACUCHO, Eduardo Marcucci, et al.
Publicado: (2015)

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)
por: Seidel, Christoph, et al.
Publicado: (2012)

Ototoxicity of Topical Antibiotic Ear Drops in Chronic Suppurative Otitis Media in Humans: A Review of the Literature
por: Hussain, Syed Zohaib Maroof, et al.
Publicado: (2022)

Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate
por: Rausch, Jessica L., et al.
Publicado: (2016)

Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate
por: Wu, Ting-Jung, et al.
Publicado: (2006)

Establishment of a GIST-T1 gastrointestinal stromal tumour cell line resistant to imatinib mesylate
por: Zhou, Yongjian, et al.
Publicado: (2018)

Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data
por: den Hollander, Dide, et al.
Publicado: (2022)

LAPAROSCOPIC RESECTION OF GASTROINTESTINAL STROMAL TUMORS (GIST)
por: LOUREIRO, Marcelo de Paula, et al.
Publicado: (2016)

Primary omental Gastrointestinal stromal tumor (GIST)
por: Todoroki, Takeshi, et al.
Publicado: (2007)

Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs)
por: Vetto, John T
Publicado: (2009)

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial
por: Adenis, A., et al.
Publicado: (2014)

Segmental resection of the duodenum for gastrointestinal stromal tumor (GIST)
por: Mennigen, Rudolf, et al.
Publicado: (2008)

Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST Patients
por: Mohammadi, Mahmoud, et al.
Publicado: (2022)

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
por: Rutkowski, Piotr, et al.
Publicado: (2017)

Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib Therapy
por: Vassos, Nikolaos, et al.
Publicado: (2021)

Reintroduction of Imatinib in GIST
por: Reid, T.
Publicado: (2013)

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)
por: Nilsson, B, et al.
Publicado: (2007)

Targeting cancers in the gastrointestinal tract: role of capecitabine
por: Saif, Muhammad Wasif
Publicado: (2009)

Laparoscopic resection of locally advanced gastrointestinal stromal tumour (GIST) of the stomach following neoadjuvant imatinib chemoreduction
por: Berney, Christophe R.
Publicado: (2015)

The Gastrointestinal Stromal Tumor (GIST) of a Pancreatic Cyst
por: Zackria, Rasiq, et al.
Publicado: (2022)

Imatinib-induced podocytopathies in a patient with gastrointestinal stromal tumor
por: Wang, Gang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f339eq2u62ap0mcp7i7l09ds7t